Key facts
- Brellium’s last known valuation is $183.0M (Dec 2025).
- It has raised $31.7M across 1 recorded rounds; the latest was Early Stage VC ($11.1M) in Nov 2024.
- Notable investors include Gaingels, Menlo Ventures, First Round Capital, Left Lane Capital, Zain S Hasan Charitable Remainder Trust — 13 tracked in total.
- Brellium has filed 1 Form D with the SEC, most recently Dec 2024 ($11.1M sold to 55 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Brellium
Funding rounds
1 roundsAbout Brellium
Developer of an AI-powered clinical compliance platform designed to ensure adherence to payor and clinical quality standards for every patient visit. The company's platform features AI-driven chart auditing, automated incident reporting, customizable compliance frameworks for single-site to enterprise-level operations, and integration with electronic health record systems, enabling healthcare providers, clinics, and behavioral health organizations to maintain documentation accuracy, streamline compliance workflows, reduce manual audit workloads, and improve the quality of care delivered.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 75
- Website
- brellium.com/
- Ownership
- Privately Held (backing)
Brellium doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brellium shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brellium in its N-PORT filings yet. We sweep new filings monthly.